BALYASNY ASSET MANAGEMENT L.P. - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$75,403
-89.2%
13,660
-83.3%
0.00%
-100.0%
Q2 2023$699,973
-37.6%
81,964
-32.8%
0.00%
-33.3%
Q1 2023$1,121,355
-10.7%
122,019
-0.8%
0.00%0.0%
Q4 2022$1,255,963123,0130.00%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,100,000$30,912,00012.48%
Miura Global Management 820,000$12,070,0007.24%
RA Capital Management 13,381,054$196,969,0004.20%
HHLR ADVISORS, LTD. 8,757,030$128,903,0003.39%
Brown Capital Management 4,406,461$64,863,0000.91%
Perceptive Advisors 1,289,534$18,982,0000.55%
Hillsdale Investment Management Inc. 344,529$5,072,0000.46%
PURA VIDA INVESTMENTS, LLC 527,164$7,760,0000.45%
Parkwood LLC 42,336$623,0000.09%
PDT Partners, LLC 31,436$463,0000.07%
View complete list of CYTEK BIOSCIENCES INC shareholders